chrisvoncsefalvay/vaers-outcomes huggingface dataset:
COVID+ 12/22/22.  Vaccination Status - Moderna x3 BRIEF OVERVIEW: Discharge Provider:  Primary Care Provider at Discharge:  Admission Date: 12/22/2022 Discharge Date: 12/27/2022   Active Hospital Problems   Diagnosis Date Noted POA ? AKI (acute kidney injury)  12/24/2022 Unknown ? COVID-19 12/22/2022 Unknown ? Atrial fibrillation with RVR 12/22/2022 Unknown ? Pleural effusion, bilateral 12/22/2022 Unknown ? Chronic combined systolic and diastolic heart failure 09/28/2022 Yes ? Valvular heart disease 09/28/2022 Yes ? Paroxysmal atrial fibrillation 09/14/2022 Yes ? Primary hypertension   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Pleural effusion [J90] Atrial fibrillation with RVR [I48.91] Acute respiratory failure with hypoxia [J96.01] COVID-19 [U07.1]   HOSPITAL COURSE: Pt. is a 83 y.o. female who presented with shortness of breath, fatigue and weakness that started roughly 5 days ago.  She denies dizziness, headache, palpitations, chest pain/pressure, fever, chills, body aches, cough, congestion, lower extremity edema.  No nausea, vomiting, diarrhea, dysuria.   Upon arrival to the emergency department she was found to be hypoxic with SpO2 79%, and tachypnea with RR 29. EKG was performed and demonstrated atrial fibrillation with RVR.  CXR demonstrated large left pleural effusion and small right pleural effusion with vascular congestion bilaterally.  BNP 10478.  Troponin 21.  Positive COVID nasal swab.  Current vital signs 95% on 2 L nasal cannula, RR 28, blood pressure 160/122, HR 154. Patient reports that her symptoms have improved since arrival however she does state that her shortness of breath continues to be moderate in intensity.  She denies pain at this time.  The above vital signs, and radiographs, labs reviewed and interpreted by me on 12/22/2022.  Patient was referred to admission to hospitalist service, inpatient progressive care unit.   Patient was diuresed with intravenous Lasix and placed on a Cardizem drip for rate control.  She underwent thoracentesis with removal of 500 mL of fluid.  With these measures she was able to be weaned off oxygen but she became mildly hypotensive.  Cardizem had to be discontinued.  She was started on digoxin for control of her heart rate with good results; however she did have some pauses with an elevated digoxin level.  Case was discussed with Cardiology to was recommended maintaining her on a beta-blocker, adding a low-dose of oral Cardizem with the patient could tolerate.  Patient continue improved but she did have some nighttime hypoxemia.  She was kept an additional day for a nighttime oxygen saturation study to possibly qualify her for oxygen. She did not qualify for oxygen. Labs and vitals are stable.Patient is eager to discharge, she has been discharged in a stable medical condition with her family.
Patient reports painful arm and difficulty sleeping at night - only reported to us 1/29/2014.
Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium, Additional Details: localized redness, swelling, and warmth just below injection site. sore, but no real pain nor itching. advised to monitor and to contact dr if it gets worse or does not improve.
Swelling of entire right thigh and right knee. Redness of entire anterior right thigh. Fever to 100.5.
My 3 month old son cried inconsolably for 3 hours or longer, very hard to where it hindered his breathing. His behavior changed from his usual and he only wanted to be held in a position he normally hates. His leg swelled up more than usual (a nurse stated this), the area was red thicker than an inch wide for an hour, he refused to eat, inability to sleep, excessive spitting up, slight diarrhea, fussiness and inconsolable crying beginning at night around 5pm until he sleeps ongoing a week after administration of vaccine (never this way before injection).
Our pharmacy mistakenly scheduled patient's second Moderna dose for 6/14/21, only three weeks after she received her first dose on 05/24/21, and she received the second dose on 6/14/21. The error was discovered on 6/16/21, and I spoke with the patient to notify her of our error. She said she has not had any adverse effects and is currently feeling fine. I asked her to notify our pharmacy if she has any adverse effects, and I provided her with the VAERS telephone number to use if needed.
Systemic: Fever-Severe, Systemic: developed whooping cough/pneumonia-Severe
I had hot/cold spells, fever, violent coughing attacks, nausea and a pounding headache for days. I still don't feel great. I spent 3 days in bed already.
Complaining of deep muscle aching with limited use of arm. ER visit 02/07/05 and Neuro visit 02/09/05.
Fever up to 103F about 4 hours after receiving the vaccine followed by a febrile seizure.  1/9/07 Received medical records from hospital which reveal patient was seen in ER on 12/14/06 afternoon after receiving flu vax in am.  Patient had awakened from nap with rash & parent found him seizing.  Temp 103.6 in ER.  Patient noted to be post ictal in ER. Final DX: febrile seizure s/p flu vaccine; mild bronchiolitis.
Nerve damage;  experincing chronic pain in neck, shoulders, arms: lower and upper extremities
very bad reaction; has gotten worse; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (very bad reaction) and CONDITION AGGRAVATED (has gotten worse) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (very bad reaction) and CONDITION AGGRAVATED (has gotten worse). At the time of the report, VACCINATION COMPLICATION (very bad reaction) and CONDITION AGGRAVATED (has gotten worse) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Patient received Moderna 0.5ml full dose instead of the 0.25 ml. I checked the company email and saw where it was approved but not the change in dosage. I called Moderna and got them to send an email on the vaccine on 10/26. I called the patient and spoke to the wife on 10/29. She stated that he had no side effects from the vaccine.
Preexisting Conditions: None. 41-year old attendee came to vaccine site on June 25, 2021 to receive COVID-19 vaccine. 5:35pm 1st dose Pfizer given L arm. 5:53pm voiced complaints of dizziness and sore throat when she stood up to leave. Not tachypneic /dyspneic. Denied feeling of throat closing up. 5:55pm V/S skin warm/dry. Sitting in chair. HR: 75 BP: 124/84  RR: 16  O2Sat%: 99%   Temp: 97. (Temporal).Last ate 12:00pm. Offered Benadryl, declined.  Patient stood up and denied dizziness and sore throat/readiness to return home. 6:05pm V/S HR 78,BP 120/88, RR 16, 02Sat%99%,Temp: 98.2F. Instructed to Contact PMD/watch for s/s of adverse reaction.  6:10pm Attendee left with mother in attendance.
On 10/13/06 patient woke up at 0600 with temperature of 101.8.  Parents administered TYLENOL, took temperature 1 hour later which was 102.3.  Patient's soft spot was swollen and bulging.  Appetite decreased, spit up 3 ounce bottle this am.  Patient has runny nose with congestion, and yellow nasal drainage.
temps 100 - 100.8 since gettings PCV13 on 11/17.
Over night started swelling and was really sore then started getting red and hot. The spot over a day started spreading across the shoulders area.
Medical assistant calling to report a temperature excursion that occurred 8/14/2020 which involved the following products: GARDASIL9, PEDVAXHIB, RECOMBIVAX, ROTATEQ. Per caller, "it would be possible that at least 100 patients have received vaccines; This spontaneous report was received from a medical assistant, concerning a 10-years-old female patient. The patient's pertinent medical history, concurrent conditions, drug reactions or allergies or concomitant medications were not reported.  On 03-SEP-2020, the patient was vaccinated with an improperly stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) 0.5 ml in the left upper arm for prophylaxis (lot # S023475, expiration date on 26-MAR-2022) (strength, dose, frequency and route of administration were not reported) (incorrect product storage).  The improperly stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) experienced a temperature excursion of 35.4 Fahrenheit degrees (°F) for the time frame of 20 minutes without a previous temperature excursion. It was confirmed that a digital data logger was involved.  This is one of several cases from the same reporter. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.devicelotnumber: S023475; expirationdate: 26-MAR-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments:  US-009507513-2009USA006106:
pt states has lost 1/2 of hair & dermatologist states pt has teloza effusion;pt reports slow healing;
given Kinrix subcutaneously; redness at the injection site; This case was reported by a nurse and described the occurrence of injection site erythema in a 4-year-old patient who received DTPa-IPV (Kinrix) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 13th December 2021, the patient received Kinrix (subcutaneous) and Kinrix Pre-Filled Syringe Device. On 13th December 2021, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced intramuscular formulation administered by other route. In December 2021, the patient experienced injection site erythema. On an unknown date, the outcome of the injection site erythema and intramuscular formulation administered by other route were unknown.   It was unknown if the reporter considered the injection site erythema to be related to Kinrix and Kinrix Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided are as follows: The nurse stated that the patient was accidentally given a dose of Kinrix subcutaneously, which led to intramuscular formulation administered by other route The patient's mother reported that the patient had local reaction of redness at the injection site and sent a picture of the redness to the office. No further details were provided on the call. The reporter consented to follow-up from safety.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021258903:FU1 - deleted
Inappropriate schedule of vaccine administered; tinnitus in both ears; This is a spontaneous report from a contactable consumer, the patient. A 49-years-old male patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL9266), via unspecified route of administration on 23Mar2021 (at the age of 49 years old), as a single dose for COVID-19 immunisation. The patient previously received first dose of BNT162b2 (PFIZER COVID-19 mRNA VACCINE BIONTECH, Lot number: EL9265) via an unspecified route of administration in right arm on 02Feb2021 at 12:00 (at the age of 49 years old), as a single dose for COVID-19 immunisation. The medical history of the patient included hypertension. The patient had not received any medication within 2 weeks of vaccination. The patient was not diagnosed with COVID-19, prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient had no known allergies to medications, food or other products. The patient had not tested for COVID-19, since the vaccination. On 14Mar2021 at 12:00, the patient experienced tinnitus in both ears. The vaccine was administered outside the range of 19-42 days after the first dose.  No therapeutic measures were taken as result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the tinnitus in both ears was not recovered.   No follow-up attempts are needed. No further information is expected.
3/20/2021 began experiencing intense itching, site had been sore from initial injection and resolved.  By 3/21/2021 was swelling hurting hot and itching, by 22nd was most of upper arm , hot very red, and painful.  Started triclinolone cream, and next day husband (MD) rx'd clindamycin oral.  By 4/1/2021 finally resolved.  Filling another report for second shot also had reaction.l
Broke out in hives over entire body except the face.  Large splotches, intense itch, elevated skin temperation.  Took Benadryl, contacted pharmacy. Benadryl treatment for four days, on the fifth day symptoms began to subside.  Came down with Covid sick in bed Sunday, April 11 after 4 p.m.
I am six weeks after the second shot and am still having significant shoulder and arm pain.  I take ibuprofen to manage it.  I have trouble lifting any object such as a pitcher of water and have limited range of motion.  Once the arm warms up, I do better, but it is always aching, Debilitating it is not.  I am glad I had the vaccine and only report this to be doing my bit for information.
Left optic neuritis in pt seen and evaluated by MD in Ophthalmology. The medical record received on 2/18/04 confirms optic neuritis. Also states demyelinating neuropathy, neuralgia, neuritis, lumbago, and inattentiveness/ spacing-out.
Flu vaccine was given on 11/20/13. Patient c/o's she has experienced upper arm pain where she received the flu vaccine injection since the injection was given.
Patient has redness and swelling at injection site the day after vaccination (normal reaction). Two days later, swelling had grown larger, and she had pain in arm. Went to doctor. He diagnosed she had a skin reaction and gave her antibiotics. Symptoms have cleared up.
On 1/18/21 Day #7 developed swelling of left upper arm, pain of left shoulder and neck, which started at 4:00 PM.  It lasted until 1/22/21 or 1/23/21.  Was fine afterwards.  Took Ibuprofen doses to help with the pain. Consulted with provider (phone) who told her OK to get 2nd vaccine.
Pt recvd vax & 3-5 hrs later markedly inc apnea/bradycardia episodes this AM w/sz activity as per EEG;
I had a fever of 102 for 3 days, running nose, sore throat, body aches, joint aches, and fatigue. I tested positive for COVID-19 at an urgent care. They prescribed me molnupiravir which helped me with my symptoms.
Adverse event is that an extra vaccine dose was given. This was because when the data was imported by the CA Immunization Registry - CAIR - the dates were imported to the electronic record incorrectly. This was discovered subsequently after entering the vaccines into the record from mom's paper vaccine print-out. The dates on the paper print out make sense with the immunization schedule, unlike the dates from the import. I am reporting this to alert that there is an issue with the CAIR registry importing process, and I believe this has happened more than once.
I received the Pfizer vaccine on Wed. July 7. The next day I noticed a reddish-purple small spot on the inside of my wrist. The next day another appeared and yet another on Sat. They are flat, do not inch and are quite small. My thought is they are petechiae. I was watching a program and lesser-known side effects of the vaccine were being discussed. One was petechiae. After doing research, I read petechiae may occur in those with low platelets. I then remembered in the past when I had blood work done, my platelets were extremely low, 135. On July 13,2021 I had another platelet count done which came back at 153. I also experienced terrible headaches for weeks after the shot as well. I'm concerned about receiving any further doses due to the reaction to the first shot.
Patient Covid + on 10/06/2021 and hospitalized Per Ed Note: 89-year-old male past medical history significant for HTN, A. fib, BPH is presenting to the emergency department from ECF via EMS for Covid positive x2. Patient was found to be Covid positive at the ECF and they are not able to care for him at the care facility if he is Covid positive. Patient has no symptoms including shortness of breath, chest pain, productive cough, rhinorrhea or other URI symptoms. Patient denies any  abdominal pain, vomiting, focal paresthesias or weakness, headache, dizziness, fevers or chills, change in bowel or bladder habits, leg pain or edema or history of blood clots, or changes in medications. He denies any other modifying precipitating or relieving factors.   PMH: HTN, A. fib, BPH
11/10/21: Son sick. Patient asymptomatic on this day. Went to obtain a swab for son and herself. Son tested Covid Positive. Patient tested Covid Negative on 11/10/21 (Patient's first test). She is uncertain what type of swab was used. Patient called hotline (see documentation below). She was unable to isolate from son and was to complete 10+5 testing.  11/11/21: Boyfriend became symptomatic and tested covid Positive 11/11/21. She is unable to isolate. Caring for both son and boyfriend who are now covid pos. Patient remained asymptomatic. 11/12/21: Symptoms started 11/12/21- Migraines, headaches. No fever, chills, or n/v/d. Still taking care of son and boyfriend who are covid positive. Patient did not call hotline.  11/13/21: Patient quarantining with covid pos son and and boyfriend, she is still symptomatic. Went to Center to get swabbed. Tested COVID POSITIVE 11/13/21 at Center. No call to hotline documented.  11/20/21: Patient still quarantining. Called hotline to ask for clearance. Patient stating herself and family are covid positive. Asked Patient to email results from Center, awaiting results. Patient states she is not done with quarantine until 11/22/21 by Health dept. Discussed with Patient that she is to finish her quarantine. States she still has migraines and fever. Patient also states her dept asked her not to return until 11/29/21. Patient will retest 11/21/21 at center, as she is unsure if covid swab from Center was a PCR testing. Patient to call back with results and update on symptoms. Patient to not to return if still symptomatic. Will complete VAERS
Once patient is done with observation and leaving starts to feel dizzy, patient was seated and vitals taken 70/40bp, 55 pulse, 18 respirations, 98 sat, dext 124. Patient is lying down and reevaluated every 10 minutes bp 100/20, pulse 60, resp18, sat 99. Alert, conscious and oriented 13:24 patient denies any symptoms and does not show any signs. Mother was oriented (patient's mother) for any symptoms.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Nurse). The reporter is the patient.  A 57-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 06Jan2021 at 13:30 as dose 1, single (Lot number: EL1284), in right arm, on 27Jan2021 at 13:30 as dose 2, single (Lot number: EL0742), in right arm and on 13Oct2021 at 13:30 as dose 3 (booster), single (Lot number: FF2590) at the age of 56 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "elevated lipid panel" (unspecified if ongoing), notes: elevated lipid panel. The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: Treatment included Anti-viral details from 11Oct2022 to 16Oct2022 for covid 19. No nown allergies.; Sender's Comments: As there is limited information in the case provided, the causal association between the reported events with the suspect drug BNT162B2 cannot be excluded. The case will be reassessed once new information is available.
Patient got dizzy, passed out and hit her head Patient responded to touch + voice immediately Gave pt water & orange juice; called an ambulance b/c she hit her head. Ambulance arrived ~ 5:45pm & transported pt to hsp
With in a few hours I had major pain and unable to move my left arm. I could not pull up pants, get up from laying position without major pain. Could not raise  my arm to wash hair. I went to a urgent care doctor a week later and he gave me muscle relaxers and pain pills I had to wait till Dec to get a new doctor to give me referral since I was new in state. I was given exercises and muscle relaxers and a cortisone shot. Shot helped relieve alot of the pain but it keeps reaccuring over time. Iam still seeing orthopedic Dr for the pain and movement issues. I've had two cortisone shots in the past year. Ive followed the exercises given, I was diagnosed with frozen shoulder. At this time I am back having pain lifting arm over head and can,t put on seat built due to rotation issues. I also cannot sleep on left side.
Injection 1-muscle soreness for about 8 hrs at site and headache for a couple days.   Injection 2- muscle soreness at site, migraine that evening, and severe neck pain. Muscle pain in neck and shoulders for a few days causing ha?s in the evenings.
This spontaneous report as received from a pharmacist refers to an unspecified number of patients of unknown age and unknown gender. Drug reactions or allergies and pertinent medical history were unspecified. On an unknown date, an unspecified number of patients were administered improperly stored doses of PNEUMOVAX 23 (strength, dose, dose number, route and lot number were unspecified). Concomitant therapies were unspecified. The outcome of received improperly stored vaccine was unknown. This is one of several reports received from the same reporter where other patients were addministered improperly stored RECOMBIVAX HB (MARRS # 1407USA014448) and VAQTA (MARRS # 1407USA014449). Additional information is not expected because reporter refused additional contact.
Cramp in the upper extremities and from the waist down. Burning sensation throughout the body. Mobility limitation and leg pain. Low pressure. 94/73 Difficulty Breathing.
Trouble breathing, increased use of inhaler. Change of inhalers due to the severity of breathing troubles
Site: Pain at Injection Site-Mild, Additional Details: flare up of pre-existing herpes in eye